Literature DB >> 8584049

Extracellular site of action of phenylalkylamines on L-type calcium current in rat ventricular myocytes.

J W Wegener1, H Nawrath.   

Abstract

The effects of the phenylalkylamines verapamil, gallopamil, and devapamil on L-type calcium currents (ICa) were studied in ventricular myocytes from rat hearts using the whole-cell patch-clamp technique. In particular, the question was addressed, whether the pharmacological binding sites for these drugs were located at the inner and/or at the outer surface of the cell membrane. Therefore, tertiary verapamil, gallopamil, and devapamil and their corresponding quaternary derivatives were applied either from the outside or the inside of the cell membrane. Extracellular application of verapamil, gallopamil and devapamil (each at 3 microM) reduced ICa to 16.1 +/- 8.6%, 11 +/- 8.9%, and 9.3 +/- 6% of control, respectively. Intracellular application of the same substances, via the patch pipette filled with 30 microM of either verapamil, gallopamil, or devapamil, failed to depress ICa. The quaternary derivatives of the phenylalkylamines (30 microM) were ineffective both when applied extracellularly or intracellularly. It is suggested that phenylalkylamines block ICa in ventricular myocytes by acting on a binding site of the calcium channel molecule located at the outer surface of the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8584049     DOI: 10.1007/bf00168564

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  D600 blocks the Ca2+ channel from the outer surface of smooth muscle cell membrane of the rabbit intestine and portal vein.

Authors:  Y Ohya; K Terada; K Kitamura; H Kuriyama
Journal:  Pflugers Arch       Date:  1987-01       Impact factor: 3.657

2.  Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit.

Authors:  J Striessnig; B J Murphy; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 3.  Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells.

Authors:  T F McDonald; S Pelzer; W Trautwein; D J Pelzer
Journal:  Physiol Rev       Date:  1994-04       Impact factor: 37.312

4.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

5.  The voltage- and time-dependent effects of (-)-verapamil on the slow inward current in isolated cat ventricular myocardium.

Authors:  T Ehara; R Daufmann
Journal:  J Pharmacol Exp Ther       Date:  1978-10       Impact factor: 4.030

6.  Calcium tolerant ventricular myocytes prepared by preincubation in a "KB medium".

Authors:  G Isenberg; U Klockner
Journal:  Pflugers Arch       Date:  1982-10       Impact factor: 3.657

7.  Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels.

Authors:  J Striessnig; H Glossmann; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

8.  Regulation of Ca2+ current in frog ventricular myocytes by the holding potential, c-AMP and frequency.

Authors:  V J Schouten; M Morad
Journal:  Pflugers Arch       Date:  1989-10       Impact factor: 3.657

9.  Extracellular localization of the benzothiazepine binding domain of L-type Ca2+ channels.

Authors:  S Hering; A Savchenko; C Strübing; M Lakitsch; J Striessnig
Journal:  Mol Pharmacol       Date:  1993-05       Impact factor: 4.436

10.  Effects of D-600 and its optical isomers on force of contraction in cat papillary muscles and guinea-pig auricles.

Authors:  C Ludwig; H Nawrath
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

View more
  7 in total

1.  Extra- and intracellular action of quaternary devapamil on muscle L-type Ca(2+)-channels.

Authors:  S Berjukov; S Aczel; B Beyer; S D Kimball; M Dichtl; S Hering; J Striessnig
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 2.  Molecular basis of drug interaction with L-type Ca2+ channels.

Authors:  J Mitterdorfer; M Grabner; R L Kraus; S Hering; H Prinz; H Glossmann; J Striessnig
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

3.  Action of tertiary phenylalkylamines on cardiac transient outward current from outside the cell membrane.

Authors:  J W Wegener; H Nawrath
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-12       Impact factor: 3.000

4.  Barnidipine block of L-type Ca(2+) channel currents in rat ventricular cardiomyocytes.

Authors:  J W Wegener; H Meyrer; J Rupp; H Nawrath
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

5.  Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes.

Authors:  J W Wegener; E I Closs; U Förstermann; H Nawrath
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

6.  Verapamil block of T-type calcium channels.

Authors:  Pamela Bergson; Gregory Lipkind; Steven P Lee; Mark-Eugene Duban; Dorothy A Hanck
Journal:  Mol Pharmacol       Date:  2010-12-13       Impact factor: 4.436

7.  The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.

Authors:  A Schuster; L Lacinová; N Klugbauer; H Ito; L Birnbaumer; F Hofmann
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.